3 Undervalued Software Stocks Set to Jump in 2024

These software stocks are overdue for a recovery, and that should certainly happen as they move back to profit in 2024.

| More on:

Tech stocks may be climbing back from bottoming out, but when it comes to software stocks there are still a lot of gains to be made. After so many cuts over the last year, looking ahead, these software stocks are looking quite undervalued. Profit is bound to come for many, but especially the three software stocks we’re going to cover today.

So if you’re looking for substantial growth not just this year, but for several years to come, definitely consider these three on the TSX today.

Dye & Durham

Dye & Durham (TSX:DND) was once a heavy hitter, seen as potentially a software stock with the most stable set of cashflows. The company provides its software to law firms, government agencies, charities and the like. These are often long-term contracts, offering stable cash flows.

Yet after increasing pricing by a substantial amount, one of the first tech stocks to do so, shares plunged. And since then, shares haven’t really recovered. DND stock now remains quite undervalued in the opinion of analysts. And investors should consider it once more.

In fact, DND stock recently reported it would be buying back shares at a price of $12.10 per share totalling $126 million. So management clearly believes DND stock can come back to greatness, with shares now at $13 as of writing. Analysts think even more is on the way, with DND stock holding a consensus price target of $23 as of writing. So certainly keep this software stock on your radar.

Kinaxis

Another software stock to consider is Kinaxis (TSX:KXS), with the supply-chain management software company also seeing shares collapse during the last few years. Yet the tech stock really didn’t deserve the drop, given that it operates with long-term contracts from some of the largest enterprise companies in the world.

In fact, the large majority of its revenue comes from subscriptions, with the rest from professional services. It’s also worth noting that Kinaxis stock was ahead of the curve when it came to implementing artificial intelligence (AI) into its business. The company’s RapidResponse program allows it to identify not just current issues for companies, but potential ones down the road.

Yet shares of Kinaxis stock remain undervalued, with shares at just $157 as of writing. Analysts now give it a consensus price target of $220 today. And this looks quite likely, as once inflation and interest rates go down and consumption goes up, the supply-chain company will need to be running on all cylinders.

OpenText

Finally, OpenText (TSX:OTEX) is another absolutely undervalued software stock. The company develops and sells enterprise information management software, and its future also lies within AI. The main purpose of the company is content and data management for large companies and government agencies. And it has become incredibly good at it, as many Canadian investors have seen over the years.

However, AI is about to create an even bigger opportunity for the stock. OpenText stock is now spending money on expanding its AI capabilities through several vectors it aims to launch over the next few years, with one already underway. Further, it is also spending on penetrating more of the U.S. market, where there is a large opportunity.

Yet again, OpenText stock is quite valuable. Cloud bookings rose, and over US$2 billion came in from selling part of its Micro Focus business. Yet the company still saw shares drop during its recent earnings report. This came from lower earnings before interest, taxes, depreciation and amortization (EBITDA), and no guidance increase.

Yet management states there will be an increase, and it wants to make sure it follows through with that guidance. Furthermore, buybacks are also in the near future. So with shares at $55 as of writing, and trading at 2 times sales, it’s definitely a software stock to have on the books.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has positions in Kinaxis. The Motley Fool recommends Kinaxis. The Motley Fool has a disclosure policy.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »